ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Nordhealth AS (NORDH.OL)
Nordhealth AS stock price today, ATLAS forecast and fair value
Healthcare · Health Information Services · Oslo Børs · Norway
NOK 25.60▼ -3.03%
Prices as of Oct 27, 2026 · NOK
Chance of rising in 1 month
49%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Nordhealth AS in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Nordhealth AS
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Nordhealth AS a 49% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between NOK 23.38 and NOK 27.77; in 9 out of 10, between NOK 20.07 and NOK 32.35. Estimated annual volatility is 44%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- NOK 2.0B
- Market cap (USD)
- $218M
- 52-week high
- NOK 38.40
- 52-week low
- NOK 21.20
- Revenue (12 months)
- €53.1M
- Gross margin
- 23.6%
- Operating margin
- -25.6%
- Net margin
- -29.9%
- Beta
- 0.33
What this means
ATLAS does not publish a fair value for NORDH.OL right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks NORDH.OL has traded between NOK 21.20 and NOK 38.40. Today it is 33.3% below that high and 21% above its low.
Its beta is 0.33: it tends to move less than the market.
About the company
Nordhealth AS provides healthcare software solutions in Norway, Finland, Sweden, the United Kingdom, Denmark, DACH, and internationally.
Want to see everything about Nordhealth AS?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does Nordhealth AS do?
Nordhealth AS provides healthcare software solutions in Norway, Finland, Sweden, the United Kingdom, Denmark, DACH, and internationally.
What is the chance NORDH.OL goes up next month?
49%: close to a coin flip. In half of the simulated outcomes, NORDH.OL ends the month between NOK 23.38 and NOK 27.77.
How big is Nordhealth AS and what is its P/E ratio?
Nordhealth AS's market capitalization is NOK 2.0B. We do not show a P/E because it has no positive earnings to base one on.
How volatile is NORDH.OL?
ATLAS estimates annual volatility at 44%. In a typical month, half of the outcomes end between NOK 23.38 and NOK 27.77.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer